Bill Commons

NY A 1522

in committee

Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment

New York · 2025-2026 Regular Session · lower

Quick answers

Did NY A 1522 pass?

Not yet. NY A 1522 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO ALCOHOLISM AND DRUG ABUSE

What is NY A 1522 about?

Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.

Who sponsors NY A 1522?

David Weprin is the primary sponsor of NY A 1522, joined by 2 cosponsors.

Description

Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.

Introduced
Latest action
2026-01-07 — REFERRED TO ALCOHOLISM AND DRUG ABUSE
Bill type
bill
Last updated

Sponsors

  • David Weprinprimary
  • Maritza Davilacosponsor
  • Keith Browncosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-01-10

    REFERRED TO ALCOHOLISM AND DRUG ABUSE

    referral-committee

  2. 2026-01-07

    REFERRED TO ALCOHOLISM AND DRUG ABUSE

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

  • Prior session: A 6210not in this corpus
  • Companion bill: S 1817

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 1522. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.